Dr Elhassadi Highlights the Impact of a p53 Alteration in Patients With MCL

from Oncology Learning Network · host HMP Global

Ezzat Elhassadi, MD, Consultant Hematologist, University Hospital, Waterford, Ireland, discusses the impact of a p53 alteration in patients with mantle cell lymphoma (MCL); these data were presented at the EHA2021 Virtual Congress.

Episode metadata supplied by the publisher feed · Published Oct 25, 2021

Embed this episode

Attribution link and audio player

Ready to play

Dr Elhassadi Highlights the Impact of a p53 Alteration in Patients With MCL

0:00 5:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Learning Network?

This episode is 5 minutes long.

When was this Oncology Learning Network episode published?

This episode was published on October 25, 2021.

Can I download this Oncology Learning Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!